Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,836 | 18,151 | 68,027 | 22,724 | 11,232 |
| Marketable Securities | 150,586 | 181,443 | 138,888 | 30,998 | 53,151 |
| Receivables | 1,802 | 838 | 329 | 1,108 | 1,015 |
| TOTAL | $197,843 | $202,925 | $208,992 | $55,918 | $66,698 |
| Non-Current Assets | |||||
| PPE Net | 3,815 | 3,813 | 4,044 | 4,116 | 4,031 |
| Intangibles | 30,690 | 45,190 | 45,190 | 48,690 | 48,690 |
| Other Non-Current Assets | 3,490 | 3,842 | 3,175 | 3,780 | 3,514 |
| TOTAL | $37,995 | $52,845 | $52,409 | $56,586 | $56,235 |
| Total Assets | $235,838 | $255,770 | $261,401 | $112,504 | $122,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,362 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,048 | 568 | 950 | 1,609 | 1,174 |
| Accrued Expenses | 8,459 | 8,007 | 6,467 | 5,648 | 6,499 |
| Other current liabilities | 3,372 | N/A | 2,104 | 1,993 | 2,026 |
| TOTAL | $14,206 | $12,200 | $10,841 | $10,932 | $11,643 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 12,275 | 13,595 | 12,116 | 17,869 | 17,264 |
| TOTAL | $12,275 | $13,595 | $12,116 | $17,869 | $17,264 |
| Total Liabilities | $26,481 | $25,795 | $22,957 | $28,801 | $28,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,615 | 39,567 | 39,126 | 18,938 | 17,575 |
| Common Shares | 40 | 40 | 39 | 18 | 17 |
| Retained earnings | -1,073,096 | -1,051,196 | -1,036,972 | -1,025,941 | -1,013,316 |
| Other shareholders' equity | 2,589 | 2,608 | 2,594 | 2,597 | 2,619 |
| TOTAL | $209,357 | $229,975 | $238,444 | $83,703 | $94,026 |
| Total Liabilities And Equity | $235,838 | $255,770 | $261,401 | $112,504 | $122,933 |